The seller behind Aehr's 832% rally is Aehr itself
The $60 million at-the-market stock program that resurfaced in this week's 52-week-high coverage was armed on April 8. Fiscal 2026 shows $97.4 million of stock sold into a $3.3 million operating cash burn.
Vincent Jiangtwo-minute read
A $60 million share printer, armed in April
Roundups of Wednesday's semiconductor rally reported that Aehr Test Systems−11.37% — Aehr Test Systems, down 11.37 percent today signed William Blair and Craig-Hallum "on Wednesday" to sell up to $60 million of stock at-the-market, into a 26% jump that carried the shares to a fresh 52-week high 1. The company did sign exactly that deal, with those agents, for that amount, on a Wednesday: April 8, 2026, with the agents taking up to 3.0% commission 2. The last filing on Aehr's EDGAR docket is dated September 10 3. The printer is not this week's news; it is standing infrastructure.
Shareholders, not shipments, built the cash
Fiscal 2026, ended May 29, shows $97.4 million of net proceeds from public stock offerings against $3.3 million of cash used by operations 4. That is roughly twice what the business billed all year, on revenue that fell to $50.0 million from $59.0 million and a $7.1 million GAAP net loss 4. Cash went from $24.5 million to $116.4 million, and the share count rose 8.7% to 32.5 million 4. The stock is up 832% in a year 1.
Aehr's cash tripled in the May quarter while quarterly revenue stayed under $19 million
- Revenue
- Cash and equivalents
Data
| Revenue | Cash and equivalents | |
|---|---|---|
| Nov '24 | $13.45M | $32.22M |
| Feb '25 | $18.31M | $29.41M |
| May '25 | $14.09M | $24.53M |
| Aug '25 | $10.97M | $22.71M |
| Nov '25 | $9.88M | $30.84M |
| Feb '26 | $10.31M | $36.91M |
| May '26 | $18.84M | $116.36M |
Bulls and skeptics agree there is no room to slip
Oppenheimer initiated on 10 September at Outperform, $120 target, arguing that "rising power and package value increases the cost of late failures"; a record $41 million Sonoma order from a hyperscaler landed against an $18.8 million revenue quarter, and the FOX-XP platform entered high-volume manufacturing with a $22 million follow-on 6. The same note concedes "valuation looks rich" 6. Zacks keeps a Hold: the stock trades near triple its own three-year median on sales, and five customers carry about 70% of revenue 7. The shares ran from $79.27 on August 31 to $104.39 on September 25 8.

Aehr trades at 18.59x forward sales, triple its own three-year median
Data
| Value | |
|---|---|
| Aehr | 18.59x |
| Teradyne | 10.08x |
| Aehr 3-yr median | 6.05x |
| Industry average | 5.43x |
| Cohu | 3.86x |
A solvent sponsor, and a standing seller
The defense is real: dilution bought a debt-free ramp. Aehr enters a guided $130 million to $150 million fiscal 2027, on a $100.6 million effective backlog after record quarterly bookings of $60.7 million, holding $116 million of cash against $27 million of total liabilities 4. How much of the $60 million program remains unsold is not broken out in the filings; the next 10-Q's share count will say. Until then, every fresh high in Aehr stock is a better price at which Aehr can print more Aehr stock.
The business burned cash in six of seven quarters; only the May quarter turned positive
- Operating cash flow
- Capex
Data
| Operating cash flow | Capex | |
|---|---|---|
| Nov '24 | -$5.87M | $0.32M |
| Feb '25 | -$1.6M | $1.66M |
| May '25 | -$2.3M | $2.82M |
| Aug '25 | -$0.28M | $1.39M |
| Nov '25 | -$1.17M | $0.47M |
| Feb '26 | -$3.69M | $0.07M |
| May '26 | $1.83M | $0.13M |
Get Chips by email, free
How AI demand is reshaping chipmakers, memory and the fabs behind them. In our daily email, every weekday.







Reader comments
0 comments